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VIRAL VECTORS USEFUL IN SOYBEAN AND 
METHODS OF USE 
BACKGROUND OF THE INVENTION 
This invention relates generally to the area of plant molecu 
lar biology and more speci?cally to plant viral expression 
vectors. 
Plant virus-based vectors for expressing heterologous pro 
teins in plants present promising biotechnological tools to 
supplement conventional breeding and transgenic technol 
ogy. Considering the speed With Which a virus infection 
becomes established throughout the plant and the high yield 
of viral-encoded proteins that accumulate in plants, the use of 
viral vectors provides an attractive and cost effective means 
for the overproduction of valuable proteins in plants and for 
rapid evaluation of neW traits. 
Several different types of positive sense RNA plant viruses 
have been developed as vectors for production of recombi 
nant proteins and peptides (Pogue et al., Annu. Rev. Phylo 
palhol. 40:45-74 (2002); Scholthof et al., Annu. Rev. Phylo 
palhol. 341299-323 (1996)). Depending on the structure of 
the viruses involved and their genome replication and expres 
sion strategies, a number of approaches including gene 
replacement, gene insertion, epitope presentation, and 
complementation have been utiliZed. Plant viral vectors are 
presently available for recombinant protein expression in a 
Wide range of host plants including Nicoliana benlhamiana, 
tobacco, squash, cucumber, Wheat, barley, coWpea, Nicoliana 
clevelandii, Chenopodium quinoa, andArabidopsis (Allison 
et al., .1. Wrol. 6213581-3588 (1998); Brisson et al., Nature 
3101511-514 (1984); Choi etal.,Planz.1. 231547-555 (2000); 
Constantin et al., Plant .1. 401622-631 (2004); Dolja et al., 
Proc. Natl. Acad. Sci. USA. 89110208-10212 (1992); 
FemandeZ-FemandeZ et al., Wrology 2801283-291 (2001); 
French et al., Science 23111294-1297 (1986); Gopinath et al., 
Wrology 2671159-173 (2000); HagiWara et al., .1. Virol. 
7317988-7993 (1999); Haupt et al., Plant Physiol. 1251209 
218 (2001); Lacomme et al., Plant .1. 341543-553 (2003); 
Tumage et al., Plant .1. 301107-117 (2002)). Even With these 
advances, there are only a limited number of plant viral vec 
tors that are suitable for systemic expression of foreign pro 
teins in major crops like soybean. Soybean is a main source of 
oil and high-quality protein WorldWide, and there is critical 
need for tools that alloW for rapid evaluation of neW traits 
involving expression of valuable proteins that confer disease/ 
pest resistance and/or those that enhance the commercial 
value of soybean. 
Thus, there exists a need for reagents useful for expressing 
heterologous proteins in plants such as soybean and deter 
mining the function of plant genes. The present invention 
satis?es these needs and provide related advantages as Well. 
SUMMARY OF INVENTION 
The invention provides Bean pod mottle virus (BPMV) 
vectors useful for expression of heterologous proteins in 
plants such as soybean. The BPMV vectors are also useful for 
virus-induced gene silencing. The invention also provides 
methods for expressing a heterologous polypeptide in a plant 
such as soybean. The invention additionally provides meth 
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2 
ods for virus-induced gene silencing, particularly in a soy 
bean plant, Which can be used to determine the function of a 
gene of interest. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The patent or application ?le contains at least one draWing 
executed in color. Copies of this patent or patent application 
publication With color draWings Will be provided by the 
O?ice upon request and payment of the necessary fee. 
FIGS. 1A-1C shoWs a schematic representation of BPMV 
RNA2 vector constructs. FIG. 1A shoWs the genome organi 
Zation of BPMV RNA2 and vector construction strategy. 
RNA2 is translated into tWo overlapping carboxy coterminal 
polyproteins. CR, RNA2 replication cofactor; MP, movement 
protein; L-CP, large coat protein; S-CP, small coat protein. A 
foreign gene (GFP) is inserted betWeen MP and L-CP coding 
sequences. The cleavage site (QM; boxed) is duplicated With 
the 8 C-terminal amino acids of the MP and the 19 N-terminal 
amino acids of the L-CP included for e?icient processing. 
Amino acids, in the one-letter code, (SEQ ID NO: 1), are 
indicated above the nucleotide sequences (SEQ ID NO: 26, 
SEQ ID NO: 27 and SEQ ID NO: 28). Altered nucleotides are 
printed in red in loWercase. The GFP gene is shoWn as a green 
box. The introduced restriction sites, SWaI and AatII, are 
boxed. FIG. 1B shoWs a schematic presentation of BPMV 
RNA2 vector constructs. The upper sequence shoWs con 
struct pGG7R2 -GFP With GFP inserted betWeen tWo arti?cial 
proteolytic cleavage sites; the designation G7R2 indicates 
that RNA2 Was derived from BPMV strain G7. The loWer 
sequence shoWs construct pGG7R2-V, Which is a modi?ed 
version of construct pGG7R2-GFP, contains additional 
restriction sites for cloning of foreign genes. A foreign gene 
can be cloned as a BamHI-MscI fragment in the pGG7R2-V 
vector after the vector is digested With same tWo enZymes. 
Alternatively, the foreign gene can be blunt-end ligated into 
MscI-digested pGG7R2-V vector. FIG. 1C shoWs a diagram 
matic representation of the proteins expressed from the 
BPMV RNA2 vector listed in increasing order of their sizes: 
P19, Tomato bushy stunt virus P19 protein; Bar, phosphino 
thricin acetyltransferase; DsRed, DsRed red ?uorescent pro 
tein; GFP, green ?uorescent protein; TCVCP, Turnip crinkle 
virus coat protein; HCPro, potyvirus helper component-pro 
tease protein. 
FIGS. 2A-2D shoWs green ?uorescence on inoculated and 
systemic leaves of soybean plants. Soybean seedlings Were 
inoculated on their primary leaves With leaf extracts prepared 
from plants infected With the BPMV-GFP construct after four 
serial passages in soybean. Alternatively, the primary leaves 
Were inoculated With the Wild-type K-Hol isolate or mock 
inoculated With buffer only. The primary leaf (FIG. 2A) and 
second trifoliolate leaf (FIG. 2B) from a soybean plant, pre 
viously inoculated With the BPMV-GFP construct, shoWed 
intense green ?uorescence under UV light. No ?uorescence 
Was detected on the mock-inoculated primary leaf (FIG. 2C) 
or on the second trifoliolate of K-Hol -infected plants (FIG. 
2D). Leaves in FIGS. 2A, 2B, and 2D shoWed symptoms 
typical of isolate K-Hol; mosaic and necrosis on inoculated 
leaves and mottling on systemic leaves. All leaves Were pho 
tographed under UV light 11 days postinoculation. 
FIGS. 3A-3B shoWs immunoblot analysis of total proteins 
from soybean plants infected With GFP constructs. FIG. 3A 
shoWs Western blot analysis using an anti-GFP antiserum. 
Samples of total proteins (15 pg) extracted from soybean 
plants subjected to the folloWing treatments were used: mock 
inoculated (1st trifoliolate; lane 1), Wild-type BPMV K-G7 
infected (1 st trifoliolate; lane 2), pGG7R2-GFP-infected (1st 
US 7,618,815 B2 
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and 2nd trifoliolate leaves; lanes 3 and 4, respectively), and 
pGHoR2-GFP-infected (1 st and 2nd trifoliolate leaves; lanes 
5 and 6, respectively). Puri?ed His6-tagged GFP protein (50 
ng) Was included in lane 7. Lane M contains loW molecular 
Weight protein markers. In FIG. 3B, levels of protein loading 
Were assessed by SDS-PAGE analysis and Coomassie blue 
staining of the proteins tested in FIG. 3A. 
FIGS. 4A-4C shoWs the stability of the GFP and DsRed 
genes expressed from the BPMV vectors. FIGS. 4A and 4B 
shoW Northern blot hybridization analysis to assess the sta 
bility of foreign gene inserts. RNA extracted from puri?ed 
virions from soybean plants previously inoculated With the 
folloWing virus isolates or transcripts Were used: 1, Wild-type 
strain K-Hol; 2, Wild-type strain K-G7; 3, pGHoRl+ 
pGG7R2-GFP transcripts; 4, pGHoRl+pGG7R2-DsRed 
transcripts; 5, pGHoRl+pGHoR2-GFP transcripts; and 6, 
pGHoRl +pGHoR2-DsRed transcripts. In FIG. 4A, a probe 
speci?c for K-Hol RNA2 (type II) Was used. In FIG. 4B, a 
probe speci?c for K-G7 RNA2 (type I) Was used. Note that 
the recombinant RNA2 constructs containing GFP or DsRed 
(lanes 3-6) are larger in siZe than those of the Wild-type RNA2 
(lanes 1 and 2). In FIG. 4C, levels of RNA loading Were 
assessed by ethidium bromide staining of viral RNA. 
FIG. 5 shoWs herbicide resistance in soybean conferred by 
infection With the BPMV vector expressing the bar gene. 
Soybean seedlings Were inoculated onto the primary leaves 
With either Wild-type virus, transcripts from the BPMV-bar 
construct, transcripts from the BPMV-GFP construct, or 
mock-inoculated With buffer alone. The herbicide treatment 
(0.1% amino glufosinate in deioniZed Water) Was applied to 
all plants When the second trifoliolate leaves Were fully 
expanded. Photographs Were taken 20 days after the herbicide 
treatment. Soybean plants infected With: BPMV-bar con 
struct (FIG. 5A); mock-inoculated control (FIG. 5B); Wild 
type BPMV strain K-G7 (FIG. 5C); and BPMV-GFP con 
struct (FIG. 5D) are shoWn. 
FIG. 6 shoWs enhancement of symptom severity in soy 
bean plants infected With the BPMV vector carrying knoWn 
viral suppressors of RNA silencing. Photographs of ?rst tri 
foliolate leaves from soybean plants inoculated With leaf 
extracts from plants infected With transcripts from pGHoRl 
plus transcripts from: pGG7R2 (panel 2); pGG7R2-P19 
(panel 3); pGG7R2-TCVCP (panel 4); pGG7R2-HCPro(S7) 
(panel 5); or pGG7R2-HCPro(T) (panel 6) are shoWn. A 
mock-inoculated control plant is shoWn in panel 1. Note 
enhanced symptom severity including necrosis on soybean 
plants infected With BPMV constructs carrying suppressors 
of RNA silencing (panels 3-6). The photographs Were taken 2 
Weeks postinoculation. 
FIG. 7 shoWs virus-induced gene silencing (VIGS) of the 
soybean PDS gene. FIGS. 7A and 7B shoW phenotypes of 
soybean plants 21 days postinoculation With the BPMV vec 
tor carrying a fragment of the soybean PDS gene (pGG7R2 
PDS) and empty vector control (pGG7R2), respectively. 
FIGS. 7C-7F shoW representative 3rd trifoliolate leaves from 
soybean plants previously inoculated With the pGG7R2-PDS 
vector shoWing different degrees of photobleaching are 
shoWn. FIG. 7G shoWs soybean plant previously inoculated 
With the vector control pGG7R2 shoWing typical mottling 
symptoms and no bleaching. FIG. 7H shoWs mock-inocu 
lated soybean plant. The photographs Were taken 21 days 
postinoculation. 
DETAILED DESCRIPTION OF THE INVENTION 
The present invention provides Bean pod mottle virus 
(BPMV) vectors useful inplants such as soybean. The BPMV 
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vectors of the invention are useful for e?icient expression of 
heterologous proteins in plants such as soybean. The BPMV 
vectors are also useful for virus-induced gene silencing. The 
invention also provides methods for expressing a heterolo 
gous polypeptide in a plant such as soybean. The present 
invention provides the ?rst plant-virus-based vector that is 
appropriate for expression of forei gn proteins in soybean. The 
invention additionally provides methods for virus-induced 
gene silencing, particularly in a soybean plant, Which can be 
used to determine the function of a gene of interest. The 
BPMV vectors of the invention advantageously alloW e?i 
cient systemic expression of foreign polypeptides and nucleic 
acids in soybean. 
BPMV is a member of the genus Comovirus in the family 
Comoviridae (Lomonossoff and Ghabrial, Encyclopedia of 
Plant Pathology, Vol. 1 (2001)). BPMV has a bipartite posi 
tive-strand RNA genome consisting of RNA1 (approximately 
6.0 kb) and RNA2 (approximately 3.6 kb) that are separately 
encapsidated in isometric particles 28 nm in diameter. TWo 
distinct subgroups of BPMV strains, designated subgroups I 
and II, have been previously isolated and extensively charac 
teriZed (Gu et al., Phylopalhology 92:446-452 (2002); Gu et 
al., Wrology 333:271-283 (2005)). The BPMV genome is 
expressed via the synthesis and subsequent proteolytic pro 
cessing of polyprotein precursors. BPMV RNA-1 codes for 
?ve mature proteins required for replication, Whereas RNA-2 
codes for a putative cell-to-cell movement protein (MP) and 
the tWo coat proteins (L-CP and SCP). As disclosed herein, 
stable BPMV-based vectors can be generated by inserting the 
gene of interest into the RNA2-encoded polyprotein open 
reading frame, betWeen the MP and L-CP coding regions, and 
constructing additional proteinase cleavage sites to ?ank the 
foreign protein. 
Plant virus-based vectors provide valuable tools for 
expression of foreign proteins in plants and for gene function 
studies. None of the previously available virus vectors is 
suitable for use in soybean. As disclosed herein, Bean pod 
mottle virus (BPMV)-based vectors are useful for gene 
expression and virus-induced gene silencing (VIGS) in plants 
such as soybean. The genes of interest Were inserted into the 
RNA2-encoded polyprotein open reading frame betWeen the 
movement protein (MP) and the large coat protein (L-CP) 
coding regions. Additional proteinase cleavage sites Were 
created to ?ank the foreign protein by duplicating the MP/L 
CP cleavage site. To minimize the chances of homologous 
recombination and thus insert instability, the nucleotide 
sequence of the duplicated regions Was altered Without affect 
ing amino acid sequences. The recombinant BPMV con 
structs Were stable folloWing several serial passages in soy 
bean and relatively high levels of protein expression Were 
attained. Successful expression of several proteins With dif 
ferent biological activities Was demonstrated from the BPMV 
vector. These included the reporter proteins GFP and DsRed, 
pho sphinothricin acetyltransferase (encoded by the herbicide 
resistance bar gene), and the RNA silencing suppressors 
encoded by Tomato bushy stunt virus, Turnip crinkle virus, 
Tobacco etch virus, and Soybean mosaic virus. The possible 
use of BPMV as a VIGS vector to study gene function in 
soybean Was also demonstrated With the phytoene desaturase 
gene. The results disclosed herein indicate that the BPMV 
based vectors are suitable for expression of foreign proteins in 
soybean and for functional genomics applications. 
In one embodiment, the invention provides a Bean pod 
mottle virus (BPMV) vector containing a nucleic acid 
sequence encoding an RNA2 polyprotein open reading frame 
(ORF), Wherein the RNA2 polyprotein ORF comprises a ?rst 
and second protease cleavage site such as a QM cleavage site, 
5 
wherein the nucleic acid sequences encoding the ?rst and 
second protease cleavage site such as a QM cleavage sites 
differ suf?ciently to reduce homologous recombination 
betWeen the QM cleavage site encoding nucleic acid 
sequences. The protease cleavage site such as a QM cleavage 
sites can be located, for example, betWeen the movement 
protein (MP) and large coat protein (L-CP) encoded by the 
RNA2 polyprotein. The vector can contain restriction sites for 
insertion of a heterologous sequence betWeen the QM cleav 
age sites. 
As used herein, a “Bean pod mottle virus vector” or 
“BPMV vector” refers to a nucleic acid vector that, on its oWn 
or in combination With other nucleic acids, is capable of 
generating BPMV When expressed in a host cell or organism. 
A BPMV vector can be, for example, a BPMV genome such 
as a genome contained in a Whole virus. In addition, a BPMV 
vector can be a plasmid encoding a portion of a BPMV 
genome. For example, as disclosed herein, a plasmid encod 
ing one of the tWo RNAs that comprise the BPMV genome 
can be used as a BPMV vector that, When combined With a 
second plasmid that contains the other RNA, results in the 
production of BPMV virus (see Examples). 
As used herein, an “RNA2 polyprotein” refers to the open 
reading frame encoded by an approximately 3.6 kb RNA, 
designated RNA2, found in BPMV, as previously described 
(see Gu et al.,. Phylopalhology 92:446-452 (2002; Gu and 
Ghabrial, Wrology 333:271-283 (2005)). A schematic repre 
sentation of the genome organization of BPMV RNA2 is 
shoWn in FIG. 1A. 
As used herein, a “protease cleavage site” refers to an 
amino acid sequence recogniZed and cleaved by a site-spe 
ci?c protease, for example, a virally-encoded site-speci?c 
protease. Site-speci?c proteases are Well knoWn in the art. In 
the case Where an expression vector such as a BPMV vector of 
the invention is to be used in a host plant such as soybean, it 
is understood that the site-speci?c protease cleavage sites 
should be recogniZed by a site-speci?c protease, for example, 
a site-speci?c protease encoded by BPMV RNAl, as dis 
closed herein. For example, in BPMV, the tWo RNA viral 
genomes express polyprotein precursors, Which are pro 
cessed post-translationally to produce mature proteins. Thus, 
appropriate proteases are expressed that alloW proper pro 
cessing of the polyprotein to mature proteins. An example of 
such a protease cleavage site is the site betWeen the movement 
protein (MP) and large coat protein (L-CP) of the RNA2 
polyprotein (see FIG. 1). Such a site is cleaved at GlnMet 
betWeen MP and L-CP and is exemplary of a “QM cleavage 
site.” 
As used herein, a “QM cleavage site” refers to a protease 
cleavage site containing GlnMet. An example of such a cleav 
age site is the GlnMet sequence that is the cleavage site 
betWeen the movement protein (MP) and large coat protein 
(L-CP) of the BPMV RNA2 polyprotein (see FIG. 1A). A QM 
cleavage site can include additional ?anking sequences, for 
example, from MP and L-CP, to increase ef?cient cleavage of 
the QM cleavage site. In a particular embodiment disclosed 
herein, the 8 C-terminal amino acids of the MP and the 19 
N-terminal amino acids of L-CP can be included to increase 
e?icient processing and cleavage of the QM cleavage site. 
Thus, a QM cleavage site can be a naturally occurring or 
arti?cial site engineered to generate a site-speci?c protease 
cleavage site, for example, a QM cleavage site ?anked by 8 
amino acids derived from the C-terminus of the MP and 19 
amino acids derived from the N-terminus of the L-CP (see 
FIG. 1A). 
In a particular embodiment, a QM cleavage site can contain 
the amino acid sequence QYNEVQAQMETNLFKLSLD 
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DVETPKGS (SEQ ID NO: 1). Although exempli?ed With this 
particular sequence, it is understood by those skilled in the art 
that shorter or longer ?anking sequences can be used, or even 
modi?cations of these sequences, so long as a suf?cient 
cleavage ef?ciency is achieved suitable for a particular appli 
cation of the BPMV vectors of the invention. One skilled in 
the art can readily determine a su?icient cleavage e?iciency, 
for example, by determining the e?iciency of production of 
BPMV, Which requires su?icient processing and cleavage of 
the RNA2 polyprotein to propagate virus. Although exempli 
?ed herein using a QM cleavage site, it is understood by those 
skilled in the art that the invention can also be practiced using 
other protease cleavage sites so long as suf?cient processing 
occurs so that BPMV is produced and is capable of propaga 
tion. 
Although exempli?ed herein as inserting a nucleic acid 
encoding a heterologous polypeptide betWeen the movement 
protein (MP) and large coat protein (L-CP) of BPMV RNA2, 
it is understood that a heterologous polypeptide can be 
inserted in other locations on RNA2, for example, betWeen 
other encoded BPMV proteins, or on RNAl so long as BPMV 
is produced and is capable of propagation. For example, a 
heterologous sequence can be inserted doWnstream from the 
small coat protein (S-CP) sequence of RNA2 With the engi 
neering of an appropriate protease cleavage site. BPMV 
RNA2 is about 3.6 kb, and BPMV RNAl is about 6 kb. 
BPMV RNAl and RNA2 are separately packaged in identical 
capsids, 28 nm in diameter, and the maximum siZe that can be 
packaged in BPMV viral capsids is about 6 kb. Therefore, a 
heterologous sequence up to about 2.4 kb can be accommo 
dated in a viral capsid encapsidating BPMV RNA2, although 
the e?iciency of expression of larger sequences may be 
reduced. It is also possible to express more than one heter 
ologous sequence, again With appropriate protease sequences 
engineered. TWo heterologous sequences can either be 
inserted at the same location, for example both betWeen the 
MP and the L-CP, or one heterologous sequence can be 
located betWeen the MP and the L-CP and the other after the 
S-CP, With appropriately engineered protease cleavage sites. 
If more than one heterologous sequence is included in BPMV 
RNA2, together the total siZe of all heterologous sequences 
included in a single BPMV RNA2 construct should not 
exceed about 2.4 kb in siZe since this Would exceed the 
capacity of the viral capsid. Alternatively, a second or addi 
tional heterologous sequence can be expressed on a separate 
RNA2 vector, and ?rst and second RNA2 vectors, each 
expressing at least one different heterologous sequence, can 
be co-infected so that more than one heterologous sequence is 
expressed. If the same protease cleavage site is engineered to 
effect cleavage of more than one heterologous sequence, the 
nucleic acid sequence encoding the protease cleavage site(s) 
can be modi?ed to minimiZe homologous recombination, as 
disclosed herein. 
In addition to using a BPMV RNA2 vector, it is possible 
that a BPMV RNAl based vector could be used to express a 
heterologous sequence by appropriate engineering of restric 
tion sites for insertion of heterologous sequences, as 
described for RNA2. RNAl contains the coding regions of 
?ve proteins: from the 5'-nd proteaase-cofactor (Co-pro), 
helicase (Hel), VPg, protease (Pro) and RNA-dependent 
RNA polymerase (RdRp). The intermediate polyproteins 
Hel+VPg and Pro+RdRp play important roles in replication. 
The cleavage site betWeen Co-pro and Hel, Which is 
glutaminezalanine (QA), is an exemplary site for inserting a 
heterologous sequence. HoWever, since the RNAl vector is 
about 6 kb and the capsid siZe limit is about 6 kb, it is likely 
that only small heterologous sequences can be accommo 
7 
dated in an RNAl-based vector. One skilled in the art can 
readily determine appropriate protease cleavage sites, clon 
ing sites and siZes of heterologous sequences suitable for 
expression from an RNAl -based vector by making such 
constructs and inoculating an appropriate plant host such as 
soybean and testing for e?icient BPMV infection. An RNAl 
-based vector With an inappropriate insert of a heterologous 
sequence can be readily determined since such a vector Would 
result in poor if any BPMV production and, conversely, an 
appropriate insert of a heterologous sequence can be deter 
mined based on su?icient BPMV production. 
As used herein, the phrase “differ suf?ciently to reduce 
homologous recombination,” refers to a difference in homol 
ogy betWeen tWo nucleic acid sequences such that the amount 
of homologous recombination betWeen the sequences is 
reduced. For example, in an embodiment of the invention in 
Which a protease cleavage site such as a QM cleavage site is 
present as tWo copies, the nucleic acid sequences encoding 
the protease cleavage sites can be similar or identical if the 
protease cleavage sites are similar or identical. In such a case, 
the homology betWeen the nucleic acid sequences encoding 
the protease cleavage site can undergo homologous recombi 
nation. In the case Where a nucleic acid encoding a heterolo 
gous polypeptide is inserted betWeen the protease cleavage 
sites, homologous recombination Would result in loss of the 
heterologous sequence and therefore decreased expression of 
the heterologous polypeptide. To minimiZe the chance of 
recombination, the nucleic acid sequences encoding the tWo 
copies of the protease cleavage site can be modi?ed based on 
the degeneracy of the genetic code such that the same amino 
acids are encoded. For example, FIG. 1 shoWs a particular 
embodiment in Which the third nucleotide of each codon is 
changed in one copy of a QM cleavage site so that the encoded 
amino acids remain the same. Although exempli?ed With one 
of the nucleic acid sequences encoding one of the protease 
cleavage sites being modi?ed, it is understoodthat one orboth 
sequences can be modi?ed so long as there is a suf?cient 
difference in homology to reduce homologous recombination 
betWeen the sequences. For example, instead of modifying 
one copy, it is possible to modify both nucleic acids, for 
example, by alternating modi?ed codons in the tWo copies, 
Which Would similarly result in reduced homology betWeen 
the tWo sequences and therefore reduce homologous recom 
bination. One skilled in the art can readily determine a differ 
ence in homology suf?cient to reduce homologous recombi 
nation, for example, by using vectors of the invention, 
inoculating a suitable host plant such as soybean and deter 
mining the amount of homologous recombination that has 
occurred. If homologous recombination has occurred at a 
level that makes a particular BPMV vector unsuitable for a 
particular use, one skilled in the art can make further changes 
in homologous sequences in order to reduce the amount of 
recombination that occurs. Furthermore, although FIG. 1 
shoWs particular changes in codons, it is understood that one 
skilled in the art can choose other codons that encode the 
same amino acid, if desired. 
Thus, in a particular embodiment, the invention provides a 
vector in Which each codon encoding the QM cleavage site 
differs betWeen the nucleic acid sequences encoding the ?rst 
QM cleavage site and the second QM cleavage site. In one 
embodiment, one of the QM cleavage sites can comprise the 
amino acid sequence QYNEVQAQMETNLFKLSLDDVET 
PKGS (SEQ ID NOzl). In another embodiment, the amino 
acid sequences of the ?rst and second QM cleavage sites are 
identical, and can be, for example, the amino acid sequence 
QYNEVQAQMETNLFKLSLDDVETPKGS (SEQ ID 
NO: 1). In still another embodiment, the vector can contain a 
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nucleic acid sequence encoding a heterologous polypeptide 
inserted betWeen the ?rst and second QM cleavage sites, for 
example, betWeen BCMV movement protein (MP) and large 
coat protein (L-CP). 
As disclosed herein and exempli?ed in FIG. 1, a BPMV 
vector can be modi?ed to include cloning sites for conve 
nience of introducing a heterologous nucleic acid into the 
vector. It is understood that suitable restriction sites, includ 
ing those disclosed herein and shoWn in FIG. 1 as Well as 
other restriction sites, can be included in a BPMV vector of 
the invention, as desired. 
As used herein, the term “heterologous,” When used in 
reference to a polypeptide, nucleic acid or gene, refers to a 
polypeptide, nucleic acid or gene that is not naturally 
expressed, for example, by a BPMV or host organism. In 
reference to a BPMV vector, heterologous refers to a 
polypeptide, nucleic acid or gene that is not naturally 
expressed by a BPMV. 
The invention also provides a method for expressing a 
heterologous polypeptide in a plant such as a soybean plant. 
The method can include the step of inoculating a soybean 
plant With Bean pod mottle virus (BPMV) RNAl and recom 
binant RNA2, Wherein the recombinant BPMV RNA2 com 
prises a nucleic acid sequence encoding an RNA2 polyprotein 
open reading frame (ORF), Wherein the RNA2 polyprotein 
ORF comprises a ?rst and second protease cleavage site such 
as a QM cleavage site, Wherein the nucleic acid sequences 
encoding the ?rst and second protease cleavage site such as a 
QM cleavage site differ suf?ciently to reduce homologous 
recombination betWeen the protease cleavage site, such as a 
QM cleavage site, encoding nucleic acid sequences and 
Wherein a nucleic acid sequence encoding a heterologous 
polypeptide is inserted betWeen the ?rst and second protease 
cleavage sites such as QM cleavage sites. In a particular 
embodiment, the method can be performed With a vector in 
Which the ?rst QM cleavage sites are located betWeen the 
movement protein (MP) and large coat protein (L-CP) 
encoded by the RNA2 polyprotein. The recombinant RNA2 
can contain restriction sites for inserting the nucleic acid 
sequence encoding the heterologous polypeptide betWeen the 
?rst and second QM cleavage sites. Other BPMV vectors, as 
disclosed herein, can also be used in a method for expressing 
a heterologous polypeptide in a plant such as soybean. Such a 
method can be used, for example, to produce large quantities 
of a polypeptide of interest. Production of such heterologous 
polypeptides can be used to produce large quantities of pro 
teins at relatively loW cost, for example, to produce a thera 
peutic polypeptide. A polypeptide can be puri?ed from the 
plant and used for therapeutic or other purposes. In addition, 
expression of a heterologous polypeptide such as an antigen 
can provide a plant or plant-derived product containing the 
antigen, Which can provide a potential loW cost oral vaccine 
containing an appropriate antigen. 
Another important application of plant viral vector systems 
is in studies on host gene function. With more plant genomic 
information available, a high throughput tool is required. 
Virus-induced gene silencing (V IGS) is an exceptional 
reverse genetics tool that can be employed to generate mutant 
phenotypes for conveying function to unknoWn genes. VIGS 
has many advantages over other methods, for example, it is 
quick and does not require plant transformation (Burch 
Smith et al., 2004). In VIGS systems, viruses are designed to 
carry partial sequence of knoWn or candidate genes in order to 
link their function to the mutant phenotype. Replication of the 
recombinant virus and generation of dsRNA intermediates 
trigger the RNA-mediated host defense system, resulting in 
degradation of RNA With sequence identity to the recombi 
US 7,618,815 B2 
nant virus including mRNA of the gene of interest. The tar 
gets of VIGS can be a single gene, several members of a gene 
family, or several distinct genes (Lu et al., EMBO J. 22, 
5690-5699 (2003a); Peele, et al., PlantJ. 27:357-366 (2001); 
Tumage, et al.,. Plant J. 30:107- 117 (2002)). Many model 
host plants including N. benthamiana, tomato, tobacco, Ara 
bidopsis, and cassava have been explored (Burch-Smith, et 
al., PlantJ. 39:734- 746 (2004)). With the current abundance 
of genomic information on soybean and model legume spe 
cies (Stacey, et al., Plant Physiol. 135:59-70 (2004)), it is 
timely to apply VIGS to soybean to enhance knowledge of 
gene function in such a major legume crop. As disclosed 
herein, BPMV vectors of the invention can be used as a VIGS 
vector for studies on gene function in soybean. 
The invention additionally provides a method for virus 
induced gene silencing in a soybean plant and vectors useful 
in a method for virus-induced gene silencing. Such a method 
can include the step of inoculating a soybean plant With Bean 
pod mottle virus (BPMV) RNA, Wherein the BPMV RNA 
comprises a nucleic acid sequence encoding at least a portion 
of a gene endogenous to the soybean plant. For virus-induced 
gene silencing, a partial or entire sequence of an endogenous 
gene can also be located in the untranslated regions (UTRs) of 
RNA2, or in RNA1 if the sequence is small enough to be 
accommodated, as discussed above, since it is the expression 
of the nucleic acid encoding at least a portion of an endog 
enous gene that results in gene silencing. For a virus-induced 
gene silencing vector, the insertion in the UTRs can be facili 
tated by engineering appropriate restriction sites for insertion 
of the endogenous gene, so long as the inserted endogenous 
sequence does not impair viral RNA replication and a su?i 
cient amount of infective BPMV is produced. 
As used herein, the term “endogenous,” When used in ref 
erence to a polypeptide, nucleic acid or gene, refers to a 
polypeptide, nucleic acid or gene that is expressed by a host. 
For example, using a BPMV vector of the invention for a 
method of virus-induced gene silencing, a BPMV vector is 
engineered to express at least a portion of a gene endogenous 
to the host plant such as soybean. In such a case, the endog 
enous gene is already expressed in the host plant. 
In one embodiment, the method for viral-induced gene 
silencing can be performed With a vector containing a nucleic 
acid sequence encoding at least a portion of an endogenous 
gene that is encoded by an RNA2 polyprotein open reading 
frame (ORF). In another embodiment, RNA2 polyprotein 
ORF can comprise a ?rst and second protease cleavage site 
such as a QM cleavage site, Wherein the nucleic acid 
sequences encoding the ?rst and second protease cleavage 
sites such as QM cleavage sites differ suf?ciently to reduce 
homologous recombination betWeen the protease cleavage 
site encoding nucleic acid sequences and Wherein the nucleic 
acid sequence encoding at least a portion of an endogenous 
gene is inserted betWeen the ?rst and second protease cleav 
age sites such as QM cleavage sites, for example, betWeen the 
movement protein (MP) and large coat protein (L-CP) 
encoded by the RNA2 polyprotein. Other vectors of the 
invention as disclosed herein can also be used in a method for 
virus-induced gene silencing. 
The results disclosed herein represent the ?rst report to 
demonstrate that BPMV-based vectors are suitable for e?i 
cient expression of heterologous proteins in soybean. The 
BPMV-RNA2 vector disclosed herein is the ?rst plant-virus 
based vector described to date that is appropriate for expres 
sion of foreign proteins in soybean. Although the CPMV 
RNA2 vector (Gopinath et al., Wrology 267: 159-173 (2000)) 
could potentially be used as an expression vector in soybean, 
it is unstable, and CPMV infection induces severe symptoms 
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on soybean (Anjos et al., Phytopathology 82:1022-1027 
(1992)). Furthermore, soybean is not a natural host for 
CPMV, and the virus is not believed to be present in the 
United States (Lomonossoff, Encyclopedia of Wralogy, 2nd 
ed pp. 285-291 (1999)). Thus, CPMV-based vectors cannot 
be released in the ?eld in the US. or other countries Where 
CPMV is not endemic for practical applications. The insta 
bility of the CPMV-RNA2 vector appears to be related to 
homologous recombination, Which may occur as a conse 
quence of duplication of the cleavage sites that border the 
inserted foreign protein. In engineering the BPMV-RNA2 
vector disclosed herein, the nucleotide sequence of the dupli 
cated regions Were altered based on degeneracy of the genetic 
code Without affecting amino acid sequence in order to mini 
miZe the chances of homologous recombination. 
The level of foreign gene expression, as exempli?ed by the 
BPMV-GFP vector, Was estimated to account for 1% of total 
soluble proteins (see Example III). This level is comparable to 
that reported for the PVX-based vectors (Culver, Wrology 
226:228-235 (1996)). 
Soybean is the top oilseed crop in the World and provides an 
extremely valuable, multi-billion dollar, source of high qual 
ity protein. It is highly desirable to increase the level of 
soybean resistance to environmental stress, targeted pests, 
and diseases in commercial varieties. The availability of the 
BPMV expression vector alloWs rapid evaluation of candi 
date proteins With antifungal or insecticidal activities as Well 
as other valuable proteins that may enhance the commercial 
value of soybean. The potential advantages that make BPMV 
an attractive vector system are that the virus (including mild 
strains) multiplies to high levels in soybean (20-50 mg virus 
from 100 g leaf tissue) and that it is stable and easily puri?ed. 
For inoculation purposes under greenhouse conditions, puri 
?ed recombinant BPMV virions or extracts from fresh or 
dried leaves from plants previously infected With the recom 
binant vector Were successfully used. Although agroinocula 
tion via leaf in?ltration is knoWn to provide the most ef?cient 
means for introducing cDNA-derived viral RNA into the 
leaves of some plant species (Lu et al., Methods 301296-303 
(2003b)), soybean leaves are dif?cult to in?ltrate, and no 
alternative conventional methods are presently available for 
soybean agroinoculation. 
The BPMV-based vector is suitable for use as a VIGS 
vector to study gene function in soybean. The bleached 
silencing phenotype of soybean plants inoculated With 
BPMV vector carrying a fragment of the soybean PDS gene 
Was stable over time as it continued to develop throughout the 
duration of the experiment (35 dpi)(see Example VI). VIGS 
has proved to provide an impressive means to study gene 
function and has also been demonstrated to be particularly 
useful in plants With genetic redundancy like soybean 
(LaWrence et al., Plant J. 36: 1 14-121 (2003)). The most 
Widely used VIGS vectors are based on potato virus X (PVX) 
or tobacco rattle virus (TRV) (Liu et al., PlantJ. 31 :777-786 
(2002); Lu et al., EMBO J. 22:5690-5699 (2003a)), and their 
applications have been mainly studied in N. benthamiana, 
Where VIGS response is generally stronger and more endur 
ing than in other plants (Lu et al., supra, 2003a). Recently, 
e?icient VIGS systems have also been developed for a feW 
additional host plants including barley, tomato, and Pisum 
sativum (Constantin et al., Plant J 40:622-631 (2004); 
HolZberg et al., Plant J. 3011-13 (2002); Liu et al., Plant J. 
31:777-786 (2002)). There is presently an urgent need for a 
VIGS vector suitable for use in soybean considering the sub 
stantial Wealth of available information on soybean genom 
ics. None of the previously establishedVIGS vectors is appro 
priate for use in soybean. Although full-length cDNA 
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infectious clones are available for the potyviruses SMV and 
Clover yellow vein virus that can infect soybean (Hajimorad 
et al., l/irology 3141497-509 (2003); Masuta et al., Plant J. 
231539-546 (2000)), neither has been evaluated as a VIGS 
vector. Potyviruses are unlikely to provide e?icient VIGS 
vectors because they encode potent suppressors of RNA 
silencing (HC-Pro proteins). HC-Pro has been shoWn to sup 
press both VIGS and transgene-induced RNA silencing 
(Anandalakshmi et al., Proc. Natl. Acad. Sci. USA. 
95113079-13084 (1998); Roth et al., Virus Res. 102197-108 
(2004)). 
The results disclosed herein With the recombinant BPMV 
PDS indicate that the BPMV-based VIGS vector induced 
e?icient and reliable gene silencing in soybean (see Example 
VI). This represents the ?rst report providing experimental 
evidence that the RNA silencing machinery is operational in 
soybean. RNA silencing (also knoWn as posttranscriptional 
gene silencing or PTGS) is implicated in the synergistic inter 
action betWeen BPMV and SMV in dually infected soybean 
plants that results in enhanced symptom severity and accu 
mulation of BPMV (Anjos et al., Phylopalhology 8211022 
1027 (1992)). This synergy is caused by SMV HC-Pro-me 
diated suppression of RNA silencing, as Was clearly 
demonstrated by inoculation of soybean With the recombi 
nant BPMV-HC-Pro construct, as disclosed herein. BPMV 
does not appear to code for any suppressors of RNA silencing. 
In a recent study, using an A grobacZerium-mediated transient 
expression system, suppression of GFP-RNA silencing in 
transgenic N. benlhamiana in?ltrated With any of the recom 
binant agrobacteria carrying BPMV coding regions for the 
primary or secondary polyprotein precursors or for any of the 
individual mature proteins Was demonstrated (Gu and 
Ghabrial, supra, 2005). In apparent contrast, the small coat 
protein (S-CP) of the related CPMV Was reported to function 
as a Weak suppressor of amplicon-induced silencing in N. 
benlhamiana (Liu et al., supra, 2004). Similar experiments 
cannot be carried out With BPMV because it does not infectN. 
benlhamiana. Assuming that BPMV S-CP, like that of 
CPMV, functions as a Weak suppressor of RNA silencing, 
such activity has little or no effect on the RNA silencing 
system of soybean, as judged by the results of the BPMV-PDS 
experiments. Therefore, in a method for viral-induced gene 
silencing, RNA silencing suppressors can optionally be 
included, as discussed above and described in Example VI. 
The inclusion of RNA silencing suppressors can enhance the 
gene silencing and effects seen from the gene silencing. 
There are presently available more than 300,000 expressed 
sequence tags (ESTs) that are derived from over 80 different 
cDNA libraries representing a Wide range of soybean organs, 
developmental stages, genotypes, and environmental condi 
tions (Stacey et al., Plant Physiol. 135159-70 (2004)). This 
soybean EST collection provides a large resource of publicly 
available genes and gene sequences that can potentially pro 
vide valuable insight into structure and function of this model 
crop legume. VIGS presents an ideal tool for large-scale 
functional genomics to convert the soybean sequence infor 
mation into functional information. The results disclosed 
herein indicate that the BPMV-based vector is suited for this 
purpose. A possible disadvantage of VIGS is that symptoms 
induced by virus infection may obscure the phenotype asso 
ciated With silencing of the gene of interest. This should not 
be a problem With the BPMV-soybean system based on cur 
rent knowledge of symptom severity determinants in BPMV. 
BPMV-induced symptom severity has recently been mapped 
to RNA1 and more speci?cally to the coding regions of the 
protease cofactor and the C-terrninal half of the putative heli 
case. Furthermore, the amino acid positions that are respon 
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sible for differences in symptom severity betWeen mild and 
severe strains Were identi?ed (Gu et al., l/irology 3331271 
283 (2005)). Since BPMV RNA2 does not play a direct role in 
symptom severity and since it is the genomic segment that 
carries the foreign gene of interest, it is then a simple matter 
to avoid interference from virus symptoms by using RNA1 
derived from a mild strain (as demonstrated With the mild 
strain K-Hal) or from a modi?ed RNA1 engineered to cause 
attenuated symptoms combined With enhanced production of 
the recombinant RNA2. 
Although exempli?ed herein With soybean, it is understood 
that a BPMV vector of the inventions can be used in other 
suitable host plant organisms that support the propagation of 
BPMV. For example, other cultivars of bean and leguminous 
Weeds are also knoWn to be hosts for BPMV (Geisler et al., 
Plant Dis. 8611280-1289 (2002)). Therefore, the vectors of 
the invention can be used in methods in other suitable host 
plants as With soybean. 
It is understood that modi?cations Which do not substan 
tially affect the activity the various embodiments of this 
invention are also provided Within the de?nition of the inven 
tion provided herein. Accordingly, the folloWing examples 
are intended to illustrate but not limit the present invention. 
EXAMPLE 1 
Methods for Generation and Analysis of BPMV 
Vectors 
Virus strains. BPMV strains KY-Hopkins 1 (K-Hol), KY 
Hancock 1 (K-Hal), and KY-Graves 7 (K-G7) have been 
previously described, and their complete nucleotides 
sequences have been reported (Gu et al., Phylopalhology 
921446-452 (2002); Gu and Ghabrial, I/irology 3331271-283 
(2005), each of Which is incorporated herein by reference). 
The nucleotide sequences are available at GenBank: K-G7, 
accession No. U70866 (version dated Mar. 16, 2001, Which is 
incorporated herein by referenc) and accession No. M62738 
(version dated Apr. 28, 1993, Which is incorporated herein by 
reference); K-Hal, RNA1, accession No. AF394606 (version 
dated Feb. 25, 2005, Which is incorporated herein by refer 
ence), RNA2, accession No. AF394607 (version dated Feb. 
25, 2005, Which is incorporated herein by reference); K-Ho 1, 
RNA1, accession No. AF394608 (version dated Feb. 25, 
2005, Which is incorporated herein by reference), RNA2, 
accession No.AF394609 (version dated Feb. 25, 2005, Which 
is incorporated herein by reference). The BPMV strains Were 
propagated in the soybean cultivar “Essex”, and infected tis 
sues Were used for virion puri?cation as previously described 
(Ghabrial et al., Plant Dis. Rep. 611690-694 (1977)). Soybean 
mosaic virus (SMV) strains G6 and G7 Were used for ampli 
?cation of the HC-Pro coding regions. SMV strain designa 
tion Was based on the differential reactions of soybean culti 
vars carrying resistance genes to SMV (Cho and Goodman, 
Phylopalhology 691467-470 (1979); GunduZ et al., Phylopa 
zhology 941687-692 (2004)). 
RNA extraction and Northern hybridization analysis. Viral 
RNA Was isolated from puri?ed virions by the sodium dode 
cyl sulfate (SDS)-phenol method (Peden and Symons, Vll’Ol 
ogy 1551487-492 (1973)). Total RNA Was extracted from 
plant tissue using a hot phenol method (VerWoerd et al., 
Nucleic Acids Res. 1712362 (1989)). For Northern blot 
hybridization analysis, the RNA samples Were denatured in 
the presence of glyoxal and dimethyl sulfoxide and separated 
by electrophoresis on a 0.8% agarose gel in 10 mM sodium 
phosphate buffer, pH 6.3 (Sambrook and Russell, Molecular 
Cloning: A Laboratory Manual, 3rd ed. Cold Spring Harbor 
Laboratory Press, NeW York (2001)). RNA Was transferred 
onto Hybond-N+ membranes, (Amersham, PiscataWay, 
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N.J.), a positively charged nylon membrane With a binding 
capacity for nucleic acids, according to the manufacturer’s 
instructions. The membranes Were then prehybridiZed, 
hybridized, and air-dried as previously described (Gu et al., 
supra, 2002). Full-length RNAl and RNA2 cDNA clones of 
strain K-G7 (strain subgroup I) or K-Hal (strain subgroup 11) 
Were used as templates for probe preparation by the 
REDIPRIME 11 random prime labeling system (Amersham), 
a DNA labeling system, according to the manufacturer’s 
instructions. The Northern blots Were exposed to a phospho 
rimager screen, and the images Were visualiZed With a PHOS 
PHORIMAGER 445 S1 system and analyZed With the 
IMAGEQUANT 4.1 software program (Amersham). 
Construction of BPMV RNA2 vectors. Full-length infec 
tious BPMV RNA2 cDNA clones (pGG7R2 and pGHoR2), 
derived from subgroup I and 11 strains, respectively, Were 
used for construction of the BPMV RNA2 vectors. Unless 
otherWise speci?ed, transcripts derived from plasmid 
pGHoRl containing a full-length infectious RNAl cDNA 
(type I, RNAl) Were used along With transcripts from recom 
binant plasmids derived from pGG7R2 or pGHoR2 in all 
inoculations. Plasmids pGHoRl, pGG7R2, and pGHoR2 
Were described previously (Gu and Ghabrial, supra, 2005). 
GFP constructs. The 5'-half of BPMV RNA2 cDNA in 
plasmids pGG7R2 or pGHoR2 (1830 bp) Was ampli?ed by 
PCR using the primer pair F1 and SWal-Rev-R2 (Table 1), 
and the PCR products Were cloned into the pGEM-T easy 
vector (Promega, Madison, Wis.). The resultant clones Were 
digested With SWal and Ncol, and tWo clones, pGG7R2-1 and 
pGHoR2-1, Were selected folloWing veri?cation by restric 
tion enZyme digestion and nucleotide sequencing. Clones 
pGG7R2-1 and pGHoR2-1 Were digested With Aatll, blunt 
ended, and self-ligated to remove the Aatll restriction site in 
the vector and to create the neW constructs pGG7R2-2 and 
pGHoR2-2. The GFPS gene Was ampli?ed using plasmid 
pZGFP (Soldevila and Ghabrial, J. l/zrol. 74:997-1003 
(2000)) as a template and the primer pair GFP-For and GFP 
Rev (Table 1). The PCR product Was cloned into the pGEM-T 
easy vector, and the resultant clone (pGGFP-l) Was veri?ed 
by sequencing. The pGG7R2-2 and pGHoR2-2 constructs 
Were digested With SWal and Sall and ligated into similarly 
digested pGGFP-l to generate constructs pGG7R2-3 and 
pGHoR2-3, respectively. The 3'-half of BPMV RNA2 cDNA 
in plasmids pGG7R2 or pGHoR2 (1841 bp) Was ampli?ed by 
PCR using the primerpairAatll-For-R2 and R1 (Table 1), and 
the PCR products Were cloned into the pGEM-T easy vector 
to generate clones pGG7R2-4 and pGHoR2-4, Which Were 
veri?ed by sequencing. Clones pGG7R2-4 and pGHoR2-4 
Were digested With Sacl and Pstl, blunt-ended, and self-li 
gated to remove the vector Sall site and to generate clones 
pGG7R2-5 and pGHoR2-5, respectively. Finally, clones 
pGG7R2-5 and pGHoR2-5 Were digested WithAatll and Sall 
and the resultant smaller fragments Were isolated and ligated 
into Aatll/Salldigested pGG7R2-3 and pGHoR2-3, respec 
tively, to produce the infectious constructs pGG7R2-GFP and 
pGHoR2-GFP. 
TABLE 1 
List of primers used to construct BPMV vectors . 
Fl TAATACGACTCACTATAGTATTAAAATTTTCATAAGA 
TTTGAAATTTTGATAAACCG 
(SEQ ID NO: 2) 
RI TTCCGCGGCCGCTATGGCCGACGTCGACTTTTTTTTT 
TTTTTTTTT 
(SEQ ID NO: 3) 
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TABLE 1 — cont inued 
List of primers used to construct BPMV vectors . 
AatII-For-RZ GGACGTCGAGACTCCAAAAGGTTCCAT 
(SEQ ID NO: 4) 
SwaI-Rev-RZ AATTTAAATAGATTTGTTTCCATTTGAGC 
(SEQ ID NO: 5) 
GFP-For AATTTAAATTGTCTCTTGATGATGTTGAAACACCCAA 
AGGATCAATGAGTAAAGGAGAAGAACTTTTCACT 
(SEQ ID NO: 6) 
GFP-Rev GGACGTCGTCCAATGAAAGCTTAAACAAGTTAGTCTC 
CATTTGTGCTTGCACCTCGTTATATTGTTTGTATAGT 
TCATCCATGCCATGTG 
(SEQ ID NO: 7) 
RFP-For ATTTAAATTGTCTCTTGATGATGTTGAAACACCCAAA 
GGATCAATGGCATCCTCTGAAGATGTTATCAAG 
(SEQ ID NO: 8) 
RFP-Rev GACGTCGTCCAATGAAAGCTTAAACAAGTTAGTCTCC 
ATTTGTGCTTGCACCTCGTTATATTGGGCGCCGGTGG 
AGTGG 
(SEQ ID NO: 9) 
VecModi-Forl AATTTAAATTGTCTCTTGATGATGTTGAAACACCC 
(SEQ ID NO: 10) 
VecModi-Revl TTGGCCAGGATCCTTTGGGTGTTTCAACATCATC 
(SEQ ID NO: 11) 
VecModi-For2 ATCGATGGCCACAATATAACGAGGTGCAAGCCCAAAT 
GGAGACC 
(SEQ ID NO: 12) 
VecModi-RevZ GACGTCGTCCAATGAAAGCTTAAACAAGTTGGTCTCC 
ATTTGGG 
(SEQ ID NO: 13) 
SMV-Af GGATCCTCCCAAAATCCTGAAGCTCAGTT 
(SEQ ID NO: 14) 
SMV-Ar ACTGTCAAAGATCCAAAAGAGTC 
(SEQ ID NO: 15) 
SMV-Bf GACTCTTTTGGATCTTTGACAGT 
(SEQ ID NO: 16) 
SMV-Br TCATCCTCTGTTGCACGATATCACCAACTCT 
(SEQ ID NO: 17) 
TEV- P2 - For GGATCCAGCGACAAATCAATCTCTGAGGCA 
(SEQ ID NO: 18) 
TEV- P2 —Rev GATATCTCCAACATTGTAAGTTTTCATTTCGGA 
(SEQ ID NO: 19) 
TB SV - P 1 9 - For CGCGGATCCATGGAACGAGCTATACAAGGA 
(SEQ ID NO: 20) 
TBSV-PlQ-Rev TGTGTTGGCCACTCGCTTTCTTTTTCGAAGGT 
(SEQ ID NO: 21) 
TCV-CP-For CGCGGATCCATGGAAAATGATCCTAGAGTC 
(SEQ ID NO: 22) 
TCV-CP-Rev ATTGGATATCAATCCTGAGTGCTTGCCATTTTCC 
(SEQ ID NO: 23) 
PDS-For CCGCGGATCCGCCGCTTGTGGCTATATATCT 
(SEQ ID NO: 24) 
PDS-Rev CACAGATATCTCCTGCACCGGCAATAACGAT 
(SEQ ID NO: 25) 
DsRed constructs. The DsRed gene Was ampli?ed by PCR 
using plasmid pDsRed2-C1 (Clontech, Palo Alto Calif.), as a 
template, and primers RFP-For and RFP-Rev (Table 1). The 
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PCR product Was cloned into the pGEM-T easy vector to 
generate clone pGdsRed-1, Which Was con?rmed by 
sequencing. The DsRed gene Was released from pGdsRed-1 
by digestion With SWaI and AatII, and the resultant fragment 
Was ligated into plasmids pGG7R2-GFP and pGHoR2-GFP, 
Which Were SWaI/AatII-digested, to replace the GFP gene and 
generate the infectious constructs pGG7R2-DsRed and 
pGHoR2-DsRed, respectively. 
Vector modi?cation. To generate a suitable BPMV-RNA2 
vector for cloning and expression of foreign genes, the GFP 
construct, pGG7R2-GFP (FIG. 1), Was modi?ed to remove 
most of the GFP sequences and to insert tWo neW restriction 
sites. To introduce a BamHI restriction site into the BPMV 
RNA2 vector, primers VecModi-Forl and VecModi-Revl, 
Which partially anneal to each other, Were subjected for PCR, 
and the product Was cloned into the pGEM-T easy vector and 
con?rmed by sequencing (pVec-Modi-l). A similar approach 
Was used to introduce a second MscI restriction site into the 
BPMV RNA2 vector; primers VecModi-For2 and VecModi 
Rev2 (Table 1), Which partially anneal to each other, Were 
subjected to PCR, and the product Was cloned into the 
pGEM-T easy vector and con?rmed by sequencing (pVec 
Modi-2). Plasmid pGG7R2-GFP Was digested With SWaI and 
MscI, and the resultant larger fragment Was isolated and 
ligated into similarly digested pVecModi-2 to generate plas 
mid pGG7R2-6. The latter Was then digested With ClaI and 
AatII, and the resultant larger fragment Was isolated and 
ligated into similarly digested pVecModi-l to generate the 
BPMV-RNA2 vector, designated pGG7R2-V (FIG. 1). 
Bar constructs. The bar gene (coding for phosphinothricin 
acetyltransferase) Was released from plasmid pBG-GD 
(Straubinger et al., Fungal Genet. Newsl. 39: 82-83 (1 992)) by 
digestion With BglII, blunt-ended With KlenoW large frag 
ment DNA polymerase (Invitrogen, Carlsbad Calif.), and 
then digested With BamHI. The DNA fragment containing the 
bar gene Was gel-puri?ed and ligated into pGG7R2-V, previ 
ously digested MscI and BamHI, to produce pGG7R2-Bar. 
Constructs of RNA silencing suppressors. TBSV P19 gene 
Was ampli?ed from plasmid PZPTBSVp19 (Qu et al., .1. Virol. 
77:511-522 (2003)) using the primer pair TBSV-P19-For and 
TBSV-P19-Rev (Table 1), and the resulting PCR product Was 
cloned into the pGEM-T easy vector. Clones in the correct 
orientation Were selected and digested With BamHI and MscI, 
and the released P19 gene Was cloned into BamHI/Mscl 
digested pGG7R2-V to produce pGG7R2-P 19. Turnip 
crinkle virus (TCV) coat protein (CP) gene Was ampli?ed 
from plasmid PZP-TCVCP (Qu et al., supra, 2003) using 
primers TCV-CP-For and TCV-CP-Rev (Table 1), and the 
resultant PCR product Was cloned into the pGEM-T easy 
vector. Clones in the correct orientation Were selected and 
digested With BamHI and EcoRV, and the released CP gene 
Was cloned into BamHI/MscI-digested pGG7R2-V to pro 
duce pGG7R2-TCP. The coding region of Tobacco etch virus 
(TEV) HC-Pro Was ampli?ed by PCR using plasmid 
pTEV7D, Which contains a full-length cDNA of TEV-RNA 
(Dolja et al., Proc. Natl. Acad. Sci. USA. 89:10208-10212 
(1992)), as a template along With primers TEV-P2-For and 
TEV-P2-Rev (Table 1). The resultant PCR product Was 
cloned into the pGEM-T easy vector, and clones in the correct 
orientation Were digested With BamHI and EcoRV. The 
released HC-Pro gene Was then cloned into BamHI/Mscl 
digested pGG7R2-V to produce pGG7R2-HCPro(T). An RT 
PCR approach Was used to clone SMV HC-Pro coding 
region. A reverse primer (SMVBr; Table 1) Was used for ?rst 
strand cDNA synthesis With total RNA from soybean leaves 
infected With SMV strains G6 or G7 and a SUPERSCRIPT II 
reverse transcription kit (Invitrogen). To eliminate a BamHI 
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site in the SMV-HC-Pro coding region Without changing the 
amino acid sequence, a tWo-step PCR method Was used. In 
the ?rst step, tWo overlapping cDNA fragments containing 
the entire HC-Pro sequence (fragments A and B covering the 
5' and 3' halves, respectively) Were PCR-ampli?ed in separate 
reactions using ?rst strand cDNA as a template and tWo pairs 
of primers (SMV-Ar and SMV-Af and SMV-Br and SMV 
Bf). The reverse primer of fragment A (SMV-Ar; 23 nucle 
otides in length) is complementary to the forWard primer of 
fragment B (SMV-Bf). Equimolar amounts of each fragment 
along With primers SMV-Br and SMV-Af Were used for the 
second step PCR. The ?nal PCR product Was cloned into the 
pGEM-T easy vector, and clones in the correct orientations 
Were con?rmed by sequencing. The inserted HCPro genes 
from strains G6 and G7 Were digested With BamHI and 
EcoRV and ligated into BamHI/MscI-digested pGG7R2 -V to 
produce pGG7R2-HCPro(S6) and pGG7R2-HCPro(S7), 
respectively. 
Phytoene desaturase (PDS) constructs. Soybean genomic 
DNA Was extracted from leaves of the soybean cultivar 
‘Essex,’ as previously described (Srinivasa et al., Phylopa 
Zhology 91:831-838 (2001)). A 318 bp PDS fragment Was 
PCR-ampli?ed using the primer pair PDS-sen5 -For and PDS 
sen5-Rev (Table 1). The PCR product Was digested With 
BamHI and EcoRV and ligated into BamHI/MscI-digested 
pGG7R2-V to generate construct pGG7R2-PDS. 
Nucleotide sequencing. All sequencing Was done using the 
BIGDYE Terminator DNA Sequencing Kit (Applied Biosys 
tems, Foster City Calif. USA) and the ABI Prism 310 genetic 
analyZer. Sequence analysis Was performed using the DNA 
strider (CEA, France) and Vector NTI programs (Informax 
Inc., Frederick, Md., USA). 
In vitro transcription and inoculation. Plasmids pGHoRl 
(containing full-length cDNA clone to type I RNA1, from 
strain K-Hol) and pCRHaRl (containing full-length cDNA 
to type II RNA1, from strain K-Hal) Were used as templates 
for in vitro transcription as previously described (Gu and 
Ghabrial, supra, 2005). After transcription, 5 pl samples of 
the reaction mixture Were analyZed on a 1% agarose gel to 
assess yield and quality of the transcripts. RNA transcripts (a 
mixture of RNA1 and RNA2 transcripts) Were used to inocu 
late fully expanded primary soybean leaves by rub inocula 
tion. 
Protein expression and Western blot analysis. Total protein 
extraction from soybean leaves Was performed as described 
by Osherov and May (Fungal Genet. Newsl. 45:38-40 
(1998)). Protein concentration Was estimated by the Bio-Rad 
protein assay method (Bio-Rad Laboratories, Hercules 
Calif.). A knoWn amount of puri?ed, bacterially expressed, 
GFP Was used as a standard in assays to assess expression 
levels of recombinant GFP. For this purpose, the Wild-type 
GFP gene Was released from plasmid pIVEX2.3 (Roche 
Applied Science, Indianapolis, Ind., USA) by digestion With 
XbaI and BamHI and cloned into pET21d vector (EMD Bio 
sciences, San Diego, Calif., USA). The resulting clone Was 
transformed into E. coli strain BL21 (DB3), and GFP expres 
sion Was induced and puri?ed according to manufacturer’s 
instructions (EMD Biosciences). Western blot analysis Was 
carried out as previously described (Srinivasa et al., supra, 
2001) using antisera to BPMV CP and GFP (Chemicon Inter 
national Inc., Temecula, Calif.). GFP expression level Was 
assessed using IMAGEQUANT v5.2 (Amersham). 
Fluorescence detection. Whole leaf green ?uorescence 
images Were acquired using BioChemi-V cooler camera 
mounted on Epi Chemi II Darkroom (UV P company, Upland, 
Calif., USA). The settings Were overhead excitation light 365 
nm and ?lter set as SYBR Green (Hoechst Blue). The Lab 
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Works Ver 4.0.0.8. software Was used for acquiring images, 
Which Were exported as TIFF ?les. 
Herbicide treatment. One-Week-old soybean seedlings 
Were inoculated With the recombinant BPMV-bar construct. 
TWo Weeks later, the infected soybean plants Were sprayed 
With the herbicide Liberty, Which contains glufosinate-am 
monium (GA) as the active ingredient (Aventis CropScience, 
Research Triangle Park, NC), at a concentration of 0. 1 % GA 
(W/v) in deioniZed Water. The soybean plants Were photo 
graphed 3 Weeks after herbicide treatment. 
EXAMPLE II 
Construction of BPMV RNA2 Vectors 
For development of BPMV as a viral vector for expression 
of heterologous proteins in soybean, the gene of interest Was 
inserted into the RNA2-encoded polyprotein ORF betWeen 
the MP and the L-CP coding regions. Additional proteinase 
cleavage sites Were created to ?ank the foreign protein by 
duplicating the MP-LCP cleavage site (as exempli?ed by the 
GFP gene construct in FIG. 1A). The coding sequences for 
the 8 C-terminal amino acids of the MP and the 19 N-terminal 
amino acids of the L-CP Were included for ef?cient process 
ing. To minimiZe the chances of homologous recombination, 
thus instability, the third nucleotide in each codon Was 
changed based on codon degeneracy (in accordance With 
BPMV codon usage) so that the encoded amino acid residues 
remained unchanged (FIG. 1A). Initially, BPMV recombi 
nant vectors expressing GFP or DsRed Were constructed and 
shoWn to be infectious and stable. Under greenhouse condi 
tions, the GFP construct Was passaged 4 times Without any 
apparent reduction in ?uorescence intensity (FIG. 2). 
The BPMV vector Was further modi?ed to include addi 
tional cloning sites (FIG. 1B); foreign genes can be cloned by 
digesting the vector pGG7R2-V With BamHI and MscI (for 
directional cloning) or by digestion With MscI (for blunt end 
cloning). TWo sets of BPMV RNA2 vectors corresponding to 
BPMV RNA2 subgroups I and II Were constructed. 
Several different genes that varied in siZe and biological 
activity Were cloned into the BPMV RNA2 vectors utiliZing 
the BamHI and MscI restriction sites in the modi?ed vector 
(FIG. 1B). In all cases, the foreign protein Was placed 
betWeen tWo arti?cial cleavage sites With duplication of 27 
virus-derived amino acids, for ef?cient processing, as 
described for the GFP constructs. These genes ranged in siZe 
from 520 bp to 1400 bp (FIG. 1C) and included the herbicide 
resistance bar gene (coding for phosphinothricin acetyltrans 
ferase) and several viral-encoded suppressors of host-medi 
ated RNA silencing. These included the P-19 and coat protein 
(CP) encoded by Tomato bushy stunt virus (TBSV) and Tur 
nip crinkle virus (TCV), respectively, and the helper compo 
nent-protease (HCPro) encoded by Soybean mosaic virus 
(SMV) and Tobacco etch virus (TEV). 
EXAMPLE III 
Expression Levels of Foreign Genes from BPMV 
Vectors 
The recombinant BPMV-GFP constructs Were used to 
evaluate foreign gene expression levels in soybean. The pri 
mary leaves of 7- to 10-day-old soybean seedlings Were 
inoculated With the BPMV-GFP constructs derived from 
either subgroup I or subgroup II BPMV RNA2. Three Weeks 
postinoculation, total soluble proteins Were extracted from 
the ?rst and second trifoliolate leaves and subjected to West 
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em blot analysis (FIG. 3). A?inity-puri?ed His-tagged GFP, 
Which Was expressed in E. coli, Was used as a control (FIG. 3, 
lane 7). Interestingly, the expression level provided by sub 
group I RNA2 vectors Was higher than that obtained With 
subgroup II RNA2 vectors in both the ?rst and second trifo 
liolate leaves (compare lanes 3 and 5, FIG. 3). To assess the 
GFP expression level, the Western blot Was scanned, and the 
generated images of band intensity Were analyZed by the 
ImageQuantTM v5.2 program (Amersham). The results indi 
cated that GFP expression level can account for as much as 
approximately 1% of total proteins in soybean. 
EXAMPLE IV 
Stability of the Foreign Gene Expressed from BPMV 
RNA2 Vectors 
To assess the stability of inserted foreign genes during 
serial plant passages, virions Were puri?ed from soybean 
plants previously infected With the BPMV-GFP or BPMV 
DsRed constructs. FolloWing three passages of the recombi 
nant BPMV vector, viral RNA Was isolated from puri?ed 
virions and subjected to Northern hybridiZation analysis 
(FIG. 4). Only a single band of the predicted siZe of the 
recombinant RNA2 containing the coding sequences for GFP 
or DsRed Was resolved. No Wild-type RNA2 Was detected 
even folloWing extended overexposure of the blots. Further 
more, ?uorescence due to expression of GFP or DsRed Was 
readily detected in the seed coats from immature seeds, sug 
gesting that the foreign genes Were stably expressed at a later 
developmental stage during pod formation. 
As disclosed herein, the BPMV-GFP vector Was stable 
after four serial passages in soybean, and no traces of Wild 
type virus Were detected by Northern hybridiZation analysis 
(FIG. 4). The ?nding that the bright green ?uorescence Was 
maintained throughout the soybean plant including the seed 
coats of immature seeds provides further evidence for the 
endured stability of the GFP construct. The BPMV-GFP vec 
tor Was also stable after three serial passages in Phaseolus 
vulgaris cv. Black Velvet. In addition to soybean and a feW 
cultivars of bean, the host range of BPMV is very limited and 
includes only some leguminous Weeds (Giesler, et al., Plant 
Dis. 86:1280-1289 (2002)). Because BPMV does not infect 
N. benlhamiana or tobacco, Which are knoWn to support the 
ampli?cation and foreign gene expression of most estab 
lished plant viral vectors, it is not possible to compare the 
BPMV-based vectors With others in regard to insert instabil 
ity. It is knoWn that ho st factors affect viral RNA replication 
and recombination and may thus contribute to reported dif 
ferences in the frequencies of viral RNA recombination 
among diverse host species (Ahlquist, et al., J. l/zrol. 7718181 
8186 (2003); Desvoyes, et al., Wrology 304:434- 442 (2002); 
DZianott, et al., Wrology 318:482-492 (2004)). It is possible 
that host factors in soybean play a role in the stability of the 
BPMV-based vectors by suppressing viral RNA recombina 
tion. 
EXAMPLE V 
Biological Activity of Gene Products Expressed 
from BPMV RNA2 Vectors 
Plants infected With the BPMV-bar construct Were resistant 
to ammoniumglufosinate When applied as a 0.1 % solution 
(W/v) in deioniZed Water (FIG. 5A). In contrast, the nonin 
oculated control, BPMV K-G7-infected plants, and plants 
infected With the BPMV-GFP construct Were killed Within 3 
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Weeks after herbicide treatment (FIG. 5). Furthermore, plants 
infected With BPMV-bar construct Were found to Withstand 
ammonium glufosinate treatment at a concentration of 1% 
(W/v) in deionized Water With little or no damage. 
It is knoWn that certain RNA silencing suppressors 
encoded by plant viruses may enhance symptom severity 
induced by heterologous viruses (Pruss et al., Plant Cells 
9:859-868 (1997); Yang and Ravelonandro, Arch. l/zrol. 147: 
2301-2312 (2002)). Three different viral RNA silencing sup 
pressors (TBSV-P19, TCV-CP, SMV-HC-Pro) With appar 
ently dissimilar underlying mechanisms (Roth et al., l/zrus 
Res. 102:97-108 (2004)) Were cloned into the BPMV vector 
and tested for their activity in soybean. The resulting con 
structs Were infectious, and the infected plants shoWed very 
severe symptoms including extensive stunting, leaf deforma 
tion, blistering, and veinal necrosis compared With the rela 
tively mild mottling symptoms induced by infections involv 
ing Wild-type BPMV RNA2 (FIG. 6). The severe symptoms 
induced by these constructs are reminiscent of the top necro 
sis syndrome induced by double infection of soybean plants 
With BPMV and SMV (Anjos et al., Phylopalhology 
82:1022-1027 (1992)). 
EXAMPLE V1 
Silencing of Phytoene Desaturase in Soybean 
Virus-induced gene silencing (VIGS) is an attractive tool 
for studies of gene function. To determine Whether a VIGS 
vector based on BPMV could be useful in silencing of endog 
enous soybean genes, a 318 bp fragment of the phytoene 
desaturase (PDS) gene, Which is necessary for production of 
carotenoid pigment production, Was inserted into the BPMV 
vector, and the resulting construct Was used to infect soybean. 
Soybean plants inoculated With the recombinant BPMV-PDS 
developed typical photobleached leaves 2 Weeks postinocu 
lation, indicating that the PDS gene had been silenced (FIG. 
7a). The BPMVPDS vector Was stable When leaf extracts 
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Were prepared from the upper leaves and used to inoculate a 
second set of healthy soybean seedlings. Representative 
upper leaves harvested at 21 dpi from the second passage 
plants are shoWn in FIG. 7. VIGS of the PDS gene Was clearly 
evident regardless of the source of RNA1 (Whether from the 
mild strain K-Hal or the severe strain K-Hol) or the soybean 
cultivar used, Essex, Clark, Williams, or York. 
Expression of RNA silencing suppressors from recombi 
nant BPMV vectors shoWed signi?cant enhancement in 
symptom severity (FIG. 6) and in the accumulation of the 
viral coat proteins, as assessed by immunoblot analysis and 
ELISA for soybean plants infected With the BPMV-HC-Pro 
construct. The enhancement in symptom severity and BPMV 
accumulation in soybean plants infected With BPMVHC-Pro 
construct is reminiscent of dual infection of soybean With 
BPMV and SMV (Anjos et al., Phylopalhology 82: 1022 
1027 (1992)) and is consistent With the idea that BPMV does 
not effectively suppress RNA silencing (Gu, et al., Wrology 
333:271-283 (2005)). Expression of RNA silencing suppres 
sors in combination With recombinant BPMV vectors may be 
useful for enhancing foreign protein expression levels (Mal 
lory, et al., Nat. Biotechnol 20:622-625 (2002);Voinnet, Plant 
J. 33 : 949-956 (2003)). Although expression of more than one 
product (suppressor plus the proteins of interest) from the 
same BPMV vector is theoretically feasible (upper limit for 
insert size is 2.4 kbp), stability might be a concern because of 
the additional duplicated cleavage sites. Thus, expression of 
RNA silencing suppressors from co-infecting recombinant 
BPMV vector is probably a better approach. 
Throughout this application various publications have 
been referenced. The disclosures of these publications in their 
entireties are hereby incorporated by reference in this appli 
cation in order to more fully describe the state of the art to 
Which this invention pertains. Although the invention has 
been described With reference to the exampled provided 
above, it should be understood that various modi?cations can 
be made Without departing from the spirit of the invention. 
SEQUENCE LISTING 
SEQ ID NO 1 
LENGTH: 27 
TYPE: PRT 
ORGANISM: Artificial Sequence 
FEATURE: 
OTHER INFORMATION: Chemically synthesized 
<400> SEQUENCE: l 
Gln Tyr Asn Glu Val Gln Ala Gln Met 
1 5 l0 
Ser Leu Asp Asp Val Glu Thr Pro Lys 
20 25 
Gly Ser 
SEQ ID NO 2 
LENGTH: 57 
TYPE: DNA 
ORGANISM: Artificial Sequence 
FEATURE: 
<400> SEQUENCE: 2 
taatacgact cactatagta ttaaaatttt cataagattt gaaattttga taaaccg 
Glu Thr Asn Leu Phe Lys Leu 
15 
OTHER INFORMATION: Primer chemically synthesized 
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—cont inued 
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<2ll> LENGTH: 46 
<2l2> TYPE: DNA 
<2l3> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Primer chemically synthesized 
<400> SEQUENCE: 3 
ttccgcggcc gctatggccg acgtcgactt tttttttttt tttttt 
<2ll> LENGTH: 27 
<2l3> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Primer chemically synthesized 
<400> SEQUENCE: 4 
ggacgtcgag actccaaaag gttccat 
<2ll> LENGTH: 29 
<2l3> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Primer chemically synthesized 
<400> SEQUENCE: 5 
aatttaaata gatttgtttc catttgagc 
<2l2> TYPE: DNA 
<2l3> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Primer chemically synthesized 
<400> SEQUENCE: 6 
aatttaaatt gtctcttgat gatgttgaaa cacccaaagg atcaatgagt aaaggagaag 
aacttttcac t 
<2ll> LENGTH: 90 
<2l3> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Primer chemically synthesized 
<400> SEQUENCE: '7 
ggacgtcgtc caatgaaagc ttaaacaagt tagtctccat ttgtgcttgc acctcgttat 
attgtttgta tagttcatcc atgccatgtg 
<2l3> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Primer chemically synthesized 
<400> SEQUENCE: 8 
atttaaattg tctcttgatg atgttgaaac acccaaagga tcaatggcat cctctgaaga 
tgttatcaag 
46 
29 
9O 
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—cont inued 
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<2ll> LENGTH: 79 
<2l3> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Primer chemically synthesized 
<400> SEQUENCE: 9 
gacgtcgtcc aatgaaagct taaacaagtt agtctccatt tgtgcttgca cctcgttata 
ttgggcgccg gtggagtgg 
<2lO> SEQ ID NO 10 
<2ll> LENGTH: 35 
<2l3> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Primer chemically synthesized 
<400> SEQUENCE: lO 
aatttaaatt gtctcttgat gatgttgaaa caccc 
<2lO> SEQ ID NO 11 
<2ll> LENGTH: 34 
<2l3> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Primer chemically synthesized 
<400> SEQUENCE: ll 
ttggccagga tcctttgggt gtttcaacat catc 
<2lO> SEQ ID NO 12 
<2ll> LENGTH: 44 
<2l3> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Primer chemically synthesized 
<400> SEQUENCE: l2 
atcgatggcc acaatataac gaggtgcaag cccaaatgga gacc 
<2lO> SEQ ID NO 13 
<2ll> LENGTH: 44 
<2l3> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Primer chemically synthesized 
<400> SEQUENCE: l3 
gacgtcgtcc aatgaaagct taaacaagtt ggtctccatt tggg 
<2lO> SEQ ID NO 14 
<2ll> LENGTH: 29 
<2l3> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Primer chemically synthesized 
<400> SEQUENCE: l4 
ggatcctccc aaaatcctga agctcagtt 
<2lO> SEQ ID NO 15 
<2ll> LENGTH: 23 
<2l2> TYPE: DNA 
<2l3> ORGANISM: Artificial Sequence 
79 
35 
34 
44 
44 
29 



